Titlebook: Cancer Regional Therapy; HAI, HIPEC, HILP, IL Yuman Fong,T. Clark Gamblin,Jonathan S. Zager Book 2020 Springer Nature Switzerland AG 2020 L

只看該作者 · 發(fā)表于 2025-3-28 22:44:00

Historical Perspective for Regional Peritoneal Therapy: HIPEC, EPIC, and Port-Based Therapyc malignancy, and malignant peritoneal mesothelioma. The methodology for administering the chemotherapy into the peritoneal space varies widely. The selection factors that are required for rational application of these treatments are necessary for benefit to occur. Hyperthermic intraperitoneal chemo

只看該作者 · 發(fā)表于 2025-3-29 01:17:37

只看該作者 · 發(fā)表于 2025-3-29 06:38:38

只看該作者 · 發(fā)表于 2025-3-29 07:34:42

只看該作者 · 發(fā)表于 2025-3-29 13:19:36

Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis eritoneal/systemic chemotherapy (NIPS), extensive intraperitoneal lavage (EIPL), and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from gastric cancer (GC-PM). Combination of these treatments is called “comprehensive treatment.” The survival rate after comprehensive tre

只看該作者 · 發(fā)表于 2025-3-29 19:06:48

Regional Therapy for the Treatment of Ovarian Cancer: HIPEC and Intraperitoneal Chemotherapyintravenous-based chemotherapies and targeted agents. However, there is strong rationale for targeting the abdominal/pelvic cavity as ovarian cancer typically involves the peritoneal lining and surfaces of organs in the abdominal and pelvic cavity. Recent clinical trials have supported utilizing reg

只看該作者 · 發(fā)表于 2025-3-29 20:28:22

Mesothelioma and Miscellaneous Disease Processeseal studding and/or ascites. Although usually advanced disease is found within the peritoneal cavity, spread beyond the abdomen is uncommonly encountered. Although advances in systemic chemotherapy have been made, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have

只看該作者 · 發(fā)表于 2025-3-30 01:11:39

Anesthetic Considerations for Regional Therapies confined to the liver pose considerable anesthetic challenges. They are lengthy and complex procedures, involving significant fluid and blood loss, evolving theories on the management of fluids, intraoperative hyperthermia, the metabolic changes, intra-abdominal hypertension associated with fluid o

只看該作者 · 發(fā)表于 2025-3-30 04:42:50

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 13:54
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved